T3	Premise 1022 1122	No between-treatment differences were observed for changes in quality of life or performance status,
T4	Premise 1127 1259	patients started on strong opioids had significantly better pain relief than patients treated according to WHO guidelines (P=0.041).
T5	Premise 1260 1502	Additionally, patients started on strong opioids required significantly fewer changes in therapy, had greater reduction in pain when a change was initiated, and reported greater satisfaction with treatment than the comparator group (P=0.041).
T6	Claim 1503 1607	Strong opioids were safe and well-tolerated, with no development of tolerance or serious adverse events.
T7	Claim 1608 1723	These data suggest the utility of strong opioids for first-line treatment of pain in patients with terminal cancer.
R1	Support Arg1:T3 Arg2:T7	
R2	Support Arg1:T6 Arg2:T7	
R3	Support Arg1:T4 Arg2:T7	
R4	Support Arg1:T5 Arg2:T7	
